• AMSTERDAM
  • BRUSSELS
  • DÜSSELDORF
  • LYON
  • MADRID
  • MANNHEIM
  • MUNICH
  • PARIS

Nieuws

New board for HOYNG ROKH MONEGIER

11 January 2018
Thu, 01/11/2018 (All day)

Benoît Strowel, a member of Hoyng Monegier’s and HOYNG ROKH MONEGIER’s executive committee since 2011, will succeed Willem Hoyng as managing partner. The other members of the executive committee are Bart van den Broek, Christine Kanz, Carl De Meyer and Luis Fernández-Novoa.

Willem will step down as managing partner after seven successful years in the position, first as managing partner of Hoyng Monegier and since 2015 as first managing partner of the new European IP Boutique HOYNG ROKH MONEGIER.

He will now dedicate his time to his busy practice and the firm’s client relationships.

Willem Hoyng: “Together with my partners, I have spent the past years creating a unique European IP  boutique firm. I think the time has come to hand over the reins.”

Benoît Strowel: “It will be a challenge to fill Willem’s shoes, but I am grateful and honored to have been chosen by my fellow partners to continue developing the firm’s European presence and  consolidating our top-tier position in intellectual property and pharmaceutical regulatory law. It is the quality of our people, not only legally and professionally but also on a personal level, which has made us such a successful and pleasant team to work for and with.  We would like to thank Willem for all he has done for the firm.”

Benoît specialises in patent litigation. He is qualified to practice law in Belgium, England and Wales and France. He splits his time between Brussels and Paris. Although a large share of his practice is in the healthcare, biotech, medical devices and pharmaceutical fields, he has handled patent cases in other areas as well, including issues pertaining to mechanical and electronics-related inventions, aviation and military inventions. Most of his work is cross-border in nature. Benoit is skilled in navigating the various jurisdictional systems in Europe and has extensive experience coordinating multi-jurisdictional patent litigation. He also has considerable expertise in the regulatory issues facing major bio-pharmaceutical companies. Benoît holds an M.Sc. in general biochemistry and molecular biology from King’s College, London.

 

  • A new edition of the Mobile World Congress (MWC), the world’s most important event in the mobile communications industry, will be held in Barcelona from 26th to 28th of February, 2019. The Commercial Courts of Barcelona have issued for the fifth consecutive year the Intellectual Property Fast Action Protocol in the framework of the Mobile World Congress.
  • The Brussels office of HOYNG ROKH MONEGIER is pleased to be one of the founding members of the Legal Diversity & Inclusion Alliance (LDIA), a collective effort by several law firms in Belgium.
  • On 27 November 2018 the Court of Appeal of The Hague in the Netherlands reversed the first instance court’s decision, confirming the validity of AstraZeneca’s patents on their breast cancer drug Faslodex® and reinstating the earlier injunction against Sandoz in PI proceedings.
  • In the landmark Philips Nokia judgement of 1 December 2011 (joined cases C 446/09 and C 495/09) the CJEU responded to a referral by the Antwerp Court of First Instance that in the context of an infringement action it is up to the holder of the intellectual property right to demonstrate that the allegedly infringing goods are intended to be put on sale in the European Union.
  • The EUIPO has released its long awaited “Study on legislative measures related to online IPR infringements”, Carina Gommers and Stephanie Hermoye drafted the Belgian submission on civil measures.